1. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells
    Naijie Liu et al, 2018, J Cell Mol Med CrossRef
  2. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
    Martina Da Ros et al, 2018, IJMS CrossRef
  3. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression
    Jing Sun et al, 2019, NeuroReport CrossRef
  4. The lncRNA ROR/miR-124-3p/TRAF6 axis regulated the ischaemia reperfusion injury-induced inflammatory response in human cardiac myocytes
    Ying-Ping Liang et al, 2019, J Bioenerg Biomembr CrossRef
  5. Micro‐RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy
    Jing‐Xuan Xu et al, 2020, Anat Rec CrossRef
  6. miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets
    Omidvar Rezaei et al, 2020, Experimental and Molecular Pathology CrossRef
  7. Drug penetration through the blood–brain barrier after radiotherapy: New approaches to bypass glioblastoma chemoresistance
    Iacopo Sardi et al, 2021 CrossRef
  8. Molecular mechanisms in temozolomide-resistant glioblastoma
    Sang Y. Lee et al, 2021 CrossRef
  9. Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling
    Ranran Dai et al, 2021, Cancer Cell Int CrossRef
  10. Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6
    Fushun Li et al, 2021, Gastroenterology Research and Practice CrossRef
  11. Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
    Jinbiao Xiong et al, 2021, ACS Omega CrossRef
  12. Hippo Pathway in Regulating Drug Resistance of Glioblastoma
    Giacomo Casati et al, 2021, IJMS CrossRef
  13. Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
    Behnoush Sohrabi et al, 2022, Cancer Gene Ther CrossRef
  14. Non-coding RNAs Enhance the Apoptosis Efficacy of Therapeutic Agents Used for the Treatment of Glioblastoma Multiform
    Shokoofeh Ghaemi et al, 2022, Journal of Drug Targeting CrossRef
  15. A bibliometric and visualization-based analysis of temozolomide research hotspots and frontier evolution
    Peng Song et al, 2022, Front. Oncol. CrossRef
  16. Comparing tumor microRNA profiles of patients with long‑ and short‑term‑surviving glioblastoma
    Björn Schneider et al, 2022, Mol Med Rep CrossRef
  17. microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
    Marianna Makowska et al, 2023, IJMS CrossRef
  18. Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance
    Xu Zhou et al, 2023, Advanced Science CrossRef
  19. TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis
    Han Xu et al, 2023, Cancer Medicine CrossRef
  20. MicroRNA-146b protects kidney injury during urinary tract infections by modulating macrophage polarization
    Changying Wang et al, 2023, mBio CrossRef
  21. Non-coding RNAs (ncRNAs) and Multidrug Resistance in Glioblastoma: Therapeutic Challenges and Opportunities
    Gehad Mohammed Subaiea et al, 2023, Pathology - Research and Practice CrossRef
  22. Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
    David Valle-Garcia et al, 2024, IJMS CrossRef
  23. Let-7b miRNA-loaded nanostructures inhibited human tongue squamous cell carcinoma metastasis by the MOR-SRC-EGFR axis
    Haojie Yang et al, 2024, Current Research in Biotechnology CrossRef
  24. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide
    Pouya Goleij et al, 2024, Mol Neurobiol CrossRef
  25. Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma
    Sanika Suvarnapathaki et al, 2024, Life CrossRef
  26. MicroRNA-146 Family: Molecular insights into their role in regulation of signaling pathways in glioma progression
    Sepideh Mirzaei et al, 2024, Pathology - Research and Practice CrossRef